First day gains for Alphamab Oncology reflect Hong Kong exchange’s growing momentum

Double digit gains by Alphamab Oncology are the latest sign that Hong Kong’s biotech chapter has shrugged off mid-year doldrums and uncertainty caused by ongoing protests. Alphamab Oncology Ltd. (HKEX:9966) rose HK$3.30 (32%) to HK$13.50 in its first day of trading Thursday, adding HK$3 billion to its market cap.

The company

Read the full 519 word article

How to gain access

Continue reading with a
two-week free trial.